According to the 5th edition of the World Health Organization (WHO) of hematolymphoid tumors, NPM1-mutated AML can be diagnosed irrespective of the percentage of blasts, based on previous observations that cases classified as MDS or MDS/MPN with NPM1 mutations quickly progressed to AML [11]. Here, NPM1 is linked to myelodysplastic syndrome.